St. Jude’s Identity
This article was originally published in The Gray Sheet
Executive Summary
Full-scale launch of the pacer line is anticipated in early 2002 following FDA approval, announced Nov. 29. A limited release will commence in December. The system, which includes dual-chamber, single-chamber, and small size models, incorporates the features of St. Jude's Integrity AFx and Integrity Micro pacemaker families, and adds additional diagnostic features including dual-channel stored electrograms, storage of information on the previous 16 Auto Mode Switch episodes, and graphic representations of the effect of the AF Suppression algorithm on atrial pacing...
You may also be interested in...
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.
Lilly Can Rest Easy As Tirzepatide Scores Phase III Sleep Apnea Win
Topline results from two studies in obstructive sleep apnea among obese adults showed efficacy crossing the 50% threshold that physicians have called clinically meaningful.
China’s Public Payer Wants To Define Innovative Drugs As Those With ‘Novel Benefits’
China’s public payer perceives innovative drugs in a different way from that of the country’s top drug regulator, a former senior healthcare security official with knowledge of the matter reveals. The posture has unnerved pharma companies, which have been hit by sharp price discounts.